| Literature DB >> 27325650 |
Daniel C Worth1, Ankur Chakravarthy2, Andrew Feber2, Patricia de Winter3, Kunal Shah1, Manit Arya1,4, Muhammad Saqib4, Raj Nigam5, Peter R Malone6, Wei Shen Tan3, Simon Rodney3, Alex Freeman7, Charles Jameson7, Gareth A Wilson2, Tom Powles8, Stephan Beck2, Tim Fenton2, Tyson V Sharp1, Asif Muneer4,9, John D Kelly3.
Abstract
Other than an association with HPV infection, little is known about the genetic alterations determining the development of penile cancer. Although penile cancer is rare in the developed world, it presents a significant burden in developing countries. Here, we report the findings of whole-exome sequencing (WES) to determine the somatic mutational landscape of penile cancer. WES was performed on penile cancer and matched germline DNA from 27 patients undergoing surgical resection. Targeted resequencing of candidate genes was performed in an independent 70 patient cohort. Mutation data were also integrated with DNA methylation and copy-number information from the same patients. We identified an HPV-associated APOBEC mutation signature and an NpCpG signature in HPV-negative disease. We also identified recurrent mutations in the novel penile cancer tumor suppressor genes CSN1(GPS1) and FAT1 Expression of CSN1 mutants in cells resulted in colocalization with AGO2 in cytoplasmic P-bodies, ultimately leading to the loss of miRNA-mediated gene silencing, which may contribute to disease etiology. Our findings represent the first comprehensive analysis of somatic alterations in penile cancer, highlighting the complex landscape of alterations in this malignancy. Cancer Res; 76(16); 4720-7. ©2016 AACR. ©2016 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27325650 PMCID: PMC5302160 DOI: 10.1158/0008-5472.CAN-15-3134
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701